Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Jan 05, 2026

BUY
$67.95 - $76.19 $339 - $380
5 Added 100.0%
10 $724,000
Q3 2024

Jan 05, 2026

BUY
$59.7 - $93.78 $298 - $468
5 New
5 $329,000
Q2 2023

Jan 05, 2026

SELL
$81.41 - $94.33 $118,940 - $137,816
-1,461 Closed
0 $0
Q1 2023

Jan 05, 2026

BUY
$74.26 - $84.51 $108,493 - $123,469
1,461 New
1,461 $121 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $53.4B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Chesapeake Asset Management LLC Portfolio

Follow Chesapeake Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesapeake Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chesapeake Asset Management LLC with notifications on news.